Breaking News

Adare Pharma Solutions Initiates Expansion of Pessano Facility in Italy

The extension at the site will accommodate a new packaging line in a purpose-built packaging hall.

Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, is adding packaging capabilities and further warehousing capacity at its Pessano facility in Milan, Italy.
 
The 20,400 square meter Pessano facility provides R&D services to expedite formulation and process development, with a seamless integrated transition to manufacturing. It can manufacture a wide range of solid dosage forms at both clinical and commercial scales, including granules, capsules, and tablets. The facility also provides controlled substance and organic solvent capabilities.
 
The two-story 2,800 square-meter extension at the site will accommodate a new packaging line in a purpose-built packaging hall.

New Packaging Line

The Marchesini Integra 220S MA260 packaging line will primarily be used to package tablets, capsules, and softgel capsules into Aclar, Triplex, PVC, PVDC, ALU/ALU blisters. The machine features integrated Robocombi ‘pick and place’ and serialization capabilities and is capable of packaging more than 50 million blisters annually. It is projected to be installed by Q4 2024.

Additional Warehouse

The expansion to the Pessano site also includes an additional 1,000 square-meter warehouse with capacity for 900 pallets, as well as space to accommodate a second packaging line for future needs.
 
“The addition of a new state-of-the-art packaging line and high-capacity warehouse expands on the comprehensive CDMO solutions Adare provides customers in Europe, the United States, and Asia,” said Tom Sellig, CEO of Adare Pharma Solutions.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters